Nicotinic receptor blockade therapy and smoking cessation
- 1 May 1991
- journal article
- review article
- Published by Wiley in British Journal of Addiction
- Vol. 86 (5) , 501-505
- https://doi.org/10.1111/j.1360-0443.1991.tb01797.x
Abstract
Smoking is a behaviour with a significant conditioned component. Attempts to quit will likely fail unless the effects of primary and secondary reinforcers are extinguished. Current smoking cessation methods scarcely address this issue, which may explain why they meet with little success in the long term. In contrast, the administration of centrally-active nicotinic receptor antagonists should provide a means of extinguishing both primary and secondary reinforcers associated with smoking. Thus, nicotine blockade therapy presents a promising new approach to smoking cessation.Keywords
This publication has 21 references indexed in Scilit:
- Reinforced alternation performance is impaired by muscarinic but not by nicotinic receptor blockade in ratsBehavioural Brain Research, 1990
- CONTROLLED TRIAL OF TRANSDERMAL NICOTINE PATCH IN TOBACCO WITHDRAWALThe Lancet, 1989
- Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trialJAMA, 1988
- Molecular studies of the neuronal nicotinic acetylcholine receptor familyMolecular Neurobiology, 1987
- META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS OF NICOTINE CHEWING-GUMThe Lancet, 1987
- Craving for CigarettesBritish Journal of Addiction, 1987
- Could Nicotine Antagonists be Used in Smoking Cessation?British Journal of Addiction, 1986
- Electrophysiological actions of nicotine on substantia nigra single unitsBritish Journal of Pharmacology, 1985
- Cigarette Craving, Smoking Withdrawal, and ClonidineScience, 1984
- Chronic central nicotinic blockade after a single administration of the bisquaternary ganglion‐blocking drug chlorisondamineBritish Journal of Pharmacology, 1984